Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study

Authors: Andrew Blauvelt, Kristian Reich, Tsen‐Fang Tsai, Stephen K. Tyring, F. Vanaclocha, Külli Kingo, Michael Ziv, Andreas Pinter, Ronald Vender, Sophie Hugot, R. You, M. Milutinovic, Diamant Thaçi - Journal of the American Academy of Dermatology 2016 cited by 304